ICAM1 and neoplasm: Blocking of the fibrin(ogen) binding sites on both monocytes (αMβ2) and tumor cells (CD54), prior to sFn treatment significantly (P < 0.05) reduced sFn mediated inhibition of monocyte/tumor cell adherence under flow conditions (Figure 7).